| EAU guidelines on non–muscle-invasive urothelial carcinoma of the bladder: update 2016 M Babjuk, A Böhle, M Burger, O Capoun, D Cohen, EM Compérat, ... European urology 71 (3), 447-461, 2017 | 1996 | 2017 |
| European association of urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ)-2019 update M Babjuk, M Burger, EM Compérat, P Gontero, AH Mostafid, J Palou, ... European urology 76 (5), 639-657, 2019 | 1878* | 2019 |
| EAU guidelines on non–muscle-invasive urothelial carcinoma of the bladder: update 2013 M Babjuk, M Burger, R Zigeuner, SF Shariat, BWG Van Rhijn, E Compérat, ... European urology 64 (4), 639-653, 2013 | 1567 | 2013 |
| European association of urology guidelines on upper urinary tract urothelial carcinoma: 2017 update M Rouprêt, M Babjuk, E Compérat, R Zigeuner, RJ Sylvester, M Burger, ... European urology 73 (1), 111-122, 2018 | 1532 | 2018 |
| Recurrence and progression of disease in non–muscle-invasive bladder cancer: from epidemiology to treatment strategy BWG Van Rhijn, M Burger, Y Lotan, E Solsona, CG Stief, RJ Sylvester, ... European urology 56 (3), 430-442, 2009 | 821 | 2009 |
| Impact of molecular subtypes in muscle-invasive bladder cancer on predicting response and survival after neoadjuvant chemotherapy R Seiler, HAD Ashab, N Erho, BWG van Rhijn, B Winters, J Douglas, ... European urology 72 (4), 544-554, 2017 | 753 | 2017 |
| Urine markers for bladder cancer surveillance: a systematic review BWG Van Rhijn, HG Van der Poel, TH van Der Kwast European urology 47 (6), 736-748, 2005 | 687 | 2005 |
| Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors C Billerey, D Chopin, MH Aubriot-Lorton, D Ricol, SGD de Medina, ... The American journal of pathology 158 (6), 1955-1959, 2001 | 597 | 2001 |
| European association of urology guidelines on upper urinary tract urothelial cell carcinoma: 2015 update M Rouprêt, M Babjuk, E Compérat, R Zigeuner, RJ Sylvester, M Burger, ... European urology 68 (5), 868-879, 2015 | 553 | 2015 |
| European guidelines on upper tract urothelial carcinomas: 2013 update M Roupreˆt, M Babjuk, E Comperat, R Zigeuner, R Sylvester, M Burger, ... European urology 63 (6), 1059-1071, 2013 | 545 | 2013 |
| The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate BWG van Rhijn, I Lurkin, F Radvanyi, WJ Kirkels, TH van der Kwast, ... Cancer research 61 (4), 1265-1268, 2001 | 382 | 2001 |
| Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome BWG Van Rhijn, AN Vis, TH Van Der Kwast, WJ Kirkels, F Radvanyi, ... Journal of clinical oncology 21 (10), 1912-1921, 2003 | 375 | 2003 |
| FGFR3, HRAS, KRAS, NRAS and PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy LC Kompier, I Lurkin, MNM van der Aa, BWG van Rhijn, TH van der Kwast, ... PloS one 5 (11), e13821, 2010 | 358 | 2010 |
| Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapy BP Schrier, MP Hollander, BWG van Rhijn, LALM Kiemeney, JA Witjes European urology 45 (3), 292-296, 2004 | 328 | 2004 |
| Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer H Zargar, PN Espiritu, AS Fairey, LS Mertens, CP Dinney, MC Mir, ... European urology 67 (2), 241-249, 2015 | 297 | 2015 |
| Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial N van Dijk, A Gil-Jimenez, K Silina, K Hendricksen, LA Smit, JM de Feijter, ... Nature medicine 26 (12), 1839-1844, 2020 | 289 | 2020 |
| FGFR3 and P53 Characterize Alternative Genetic Pathways in the Pathogenesis of Urothelial Cell Carcinoma BWG Van Rhijn, TH Van Der Kwast, AN Vis, WJ Kirkels, ER Boevé, ... Cancer research 64 (6), 1911-1914, 2004 | 283 | 2004 |
| Oncologic outcomes of kidney-sparing surgery versus radical nephroureterectomy for upper tract urothelial carcinoma: a systematic review by the EAU non-muscle invasive bladder … T Seisen, B Peyronnet, JL Dominguez-Escrig, HM Bruins, CY Yuan, ... European urology 70 (6), 1052-1068, 2016 | 275 | 2016 |
| ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, diagnosis, and molecular markers AM Kamat, PK Hegarty, JR Gee, PE Clark, RS Svatek, N Hegarty, ... European urology 63 (1), 4-15, 2013 | 274 | 2013 |
| Prognostic performance and reproducibility of the 1973 and 2004/2016 World Health Organization grading classification systems in non–muscle-invasive bladder cancer: a European … V Soukup, O Čapoun, D Cohen, V Hernandez, M Babjuk, M Burger, ... European urology 72 (5), 801-813, 2017 | 270 | 2017 |
